Virginia Basic and Translational Research Program

弗吉尼亚基础和转化研究计划

基本信息

  • 批准号:
    7640493
  • 负责人:
  • 金额:
    $ 49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-06-18 至 2012-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Adult sickle cell expertise at VCU and the Virginia CSCC is abundant. Several VCU investigators have extensive experience in the management of sickle cell disease. The Principal Investigator, Dr. Wally Smith is an internist who has cared for adults with sickle cell since almost exclusively since 1986 at two institutions, the University of Tennessee (1986-1991) and Virginia Commonwealth University Medical Center (1991-present). Dr's Smith and Dr. John Roberts, a Co-Investigator, direct the Adult Sickle Cell Program. Dr. Roberts has 9 years of experience caring for sickle cell patients. He is certified in Internal Medicine, Pediatrics, and (Adult) Medical Oncology. He is Director of Clinical Research at Massey Cancer Center. Ms. Virginia Smith, RN, FNP is the adult Sickle Cell Nurse Practitioner with over 10 years experience caring for sickle cell patients, and additional experience as a home care nurse and administrator. Pediatric sickle cell expertise at VCU is also abundant. Dr. Joseph Laver is Chairman of the Department of Pediatrics at VCU, and a pediatric hematologist/oncologist with 20 years of experience caring for sickle cell patients at the Medical University of South Carolina (MUSC) and VCU. Dr Godder, the Pediatric Hematology/Oncology Division Chair, has 18 years of experience in caring for Sickle cell disease patients at Memorial Sloan Kettering, at North Shore University Hospital/ Cornell Medical College, at the University of South Carolina, and recently at VCU. Dr. E. Clifton Russell is a Professor in pediatric hematology/oncology at VCU with >25 years of experience caring for sickle cell patients. He has the largest volume of sickle cell patients among sickle cell pediatric providers. Drs. Nancy L. Dunn and Gita V. Massey are each faculty in pediatric hematology/oncology. They each have cared for sickle cell patients for more than 10 years at VCU. Dr. Asadullah Khan is a new faculty member in pediatric hematology/oncology that also cares for sickle cell patients.
描述(由申请人提供):成人镰状细胞专家在VCU和弗吉尼亚CSCC是丰富的。几位VCU研究人员在镰状细胞病的管理方面有丰富的经验。首席研究员Wally Smith博士是一名内科医生,自1986年以来,他几乎专门在田纳西大学(1986-1991)和弗吉尼亚联邦大学医学中心(1991-至今)两个机构治疗成人镰状细胞。史密斯博士和联合研究员约翰·罗伯茨博士指导成人镰状细胞项目。罗伯茨医生有9年护理镰状细胞病人的经验。他拥有内科、儿科和(成人)肿瘤医学认证。他是梅西癌症中心临床研究主任。Virginia Smith女士,注册护士,FNP,成年镰状细胞护士从业人员,拥有超过10年的镰状细胞患者护理经验,以及作为家庭护理护士和管理员的额外经验。儿科镰状细胞专家在VCU也很丰富。Joseph Laver博士是VCU儿科系主任,也是一名儿科血液学家/肿瘤学家,在南卡罗来纳医科大学(MUSC)和VCU拥有20年镰状细胞患者护理经验。Godder博士是儿科血液学/肿瘤学系主任,在纪念斯隆凯特林、北岸大学医院/康奈尔医学院、南卡罗来纳大学和最近的VCU有18年的镰状细胞病患者护理经验。E. Clifton Russell博士是VCU儿科血液学/肿瘤学教授,拥有25年镰状细胞患者护理经验。在镰状细胞儿科医生中,他有最多的镰状细胞患者。Drs。Nancy L. Dunn和Gita V. Massey分别是儿童血液学/肿瘤学的教员。他们每个人都在VCU照顾镰状细胞患者超过10年。阿萨杜拉·汗博士是儿科血液学/肿瘤学的一名新教员,他也关心镰状细胞患者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wally R Smith其他文献

Incidence, Prevalence, and Disease Management Impactability of High Utilization in an Adult Sickle Cell Medical Home
  • DOI:
    10.1182/blood-2023-187621
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Wally R Smith;Daniel Sop;Yue May Zhang;Benjamin Jaworowski;Shirley Johnson
  • 通讯作者:
    Shirley Johnson
Towards an Implicit Measure of Patient Engagement in Sickle Cell Disease: Relationships between Implicit Measures of Engagement and Previous Childhood Trauma Among Adolescents and Young Adults
  • DOI:
    10.1182/blood-2023-187552
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Haylee Hartzog;Shirley Johnson;Rachel Walls;Yue May Zhang;Daniel Sop;Wally R Smith
  • 通讯作者:
    Wally R Smith
Oxycodone Produces Antinociception, but Worsens Functional Behaviors, in Humanized Sickle Cell Disease Mice
  • DOI:
    10.1182/blood-2022-162675
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Kennedy N Goldsborough;Molly Sonenklar;Kalpna Gupta;M Imad Damaj;Wally R Smith;Joyce Lloyd;Aron Lichtman
  • 通讯作者:
    Aron Lichtman
A Patient-Centric Approach to Sickle Cell Disease Clinical Trials: Integrating Patient Perspectives in the RISE UP Phase 2/3 Trial of Mitapivat for Informed Protocol Design and Associated Patient Community Benefit
  • DOI:
    10.1182/blood-2023-186710
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Charles R. Jonassaint;Blaze Armon Eppinger;Dominique Friend;Golie Lorenzo Green;Mia Robinson;Teonna Woolford;DeMitrious Wyant;Janie Davis;Abdulafeez Oluyadi;Ahmar U Zaidi;Holly John;Wally R Smith
  • 通讯作者:
    Wally R Smith
“It Was Bootstrap All the Way”: Exploring the Barriers and Facilitators to the Development of Non-Hematology Sickle Cell Disease Experts in the United States
  • DOI:
    10.1182/blood-2024-203728
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Francis W Coyne;Deirdra R Terrell;Valerie Lang;Ashley M Jenkins;Allison A. King;Wally R Smith
  • 通讯作者:
    Wally R Smith

Wally R Smith的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wally R Smith', 18)}}的其他基金

Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
使用患者导航仪增强羟基脲在镰状细胞病中的应用
  • 批准号:
    8268195
  • 财政年份:
    2012
  • 资助金额:
    $ 49万
  • 项目类别:
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
使用患者导航仪增强羟基脲在镰状细胞病中的应用
  • 批准号:
    8904700
  • 财政年份:
    2012
  • 资助金额:
    $ 49万
  • 项目类别:
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
使用患者导航仪增强羟基脲在镰状细胞病中的应用
  • 批准号:
    9116288
  • 财政年份:
    2012
  • 资助金额:
    $ 49万
  • 项目类别:
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
使用患者导航仪增强羟基脲在镰状细胞病中的应用
  • 批准号:
    8698808
  • 财政年份:
    2012
  • 资助金额:
    $ 49万
  • 项目类别:
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
使用患者导航仪增强羟基脲在镰状细胞病中的应用
  • 批准号:
    8529610
  • 财政年份:
    2012
  • 资助金额:
    $ 49万
  • 项目类别:
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
使用患者导航仪增强羟基脲在镰状细胞病中的应用
  • 批准号:
    9564278
  • 财政年份:
    2012
  • 资助金额:
    $ 49万
  • 项目类别:
Comparative Effectiveness of Virginia Coordinated Care versus the Traditional Saf
弗吉尼亚协调护理与传统 SAF 的效果比较
  • 批准号:
    8055657
  • 财政年份:
    2010
  • 资助金额:
    $ 49万
  • 项目类别:
MORPHINE PHARMACOKINETICS AND PHARMACODYNAMICS IN SICKLE CELL DISEASE
吗啡在镰状细胞病中的药代动力学和药效学
  • 批准号:
    8166575
  • 财政年份:
    2009
  • 资助金额:
    $ 49万
  • 项目类别:
Virginia Basic and Translational Research Program
弗吉尼亚基础和转化研究计划
  • 批准号:
    7916725
  • 财政年份:
    2008
  • 资助金额:
    $ 49万
  • 项目类别:
Virginia Commonwealth University Sickle Cell Disease
弗吉尼亚联邦大学镰状细胞病
  • 批准号:
    7060251
  • 财政年份:
    2006
  • 资助金额:
    $ 49万
  • 项目类别:

相似国自然基金

Basic helix-loop-helix(bHLH)蛋白在光信号以及油菜素甾醇调控拟南芥开花过程中的作用
  • 批准号:
    31200216
  • 批准年份:
    2012
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
Watanabe块、basic Morita等价与块扩张
  • 批准号:
    10501016
  • 批准年份:
    2005
  • 资助金额:
    14.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion Scientific Core A
红细胞输血同种免疫的基本和转化机制 科学核心 A
  • 批准号:
    10711667
  • 财政年份:
    2023
  • 资助金额:
    $ 49万
  • 项目类别:
Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion. Project 3
红细胞输注同种免疫的基本和转化机制。
  • 批准号:
    10711670
  • 财政年份:
    2023
  • 资助金额:
    $ 49万
  • 项目类别:
Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion. Project 4
红细胞输注同种免疫的基本和转化机制。
  • 批准号:
    10711671
  • 财政年份:
    2023
  • 资助金额:
    $ 49万
  • 项目类别:
Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion. Project 2
红细胞输注同种免疫的基本和转化机制。
  • 批准号:
    10711669
  • 财政年份:
    2023
  • 资助金额:
    $ 49万
  • 项目类别:
Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion. Project 1
红细胞输注同种免疫的基本和转化机制。
  • 批准号:
    10711668
  • 财政年份:
    2023
  • 资助金额:
    $ 49万
  • 项目类别:
Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion
红细胞输注同种免疫的基本机制和转化机制
  • 批准号:
    10711666
  • 财政年份:
    2023
  • 资助金额:
    $ 49万
  • 项目类别:
CMA-Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Interception of tobacco smoking-related bladder cancer by an epigenetic approach
CMA-暴露于致癌物的退伍军人尿路上皮癌症发生的基本和转化机制:通过表观遗传学方法拦截与吸烟相关的膀胱癌
  • 批准号:
    10260302
  • 财政年份:
    2022
  • 资助金额:
    $ 49万
  • 项目类别:
Training Program in Basic and Translational Pediatric Oncology Research
基础和转化儿科肿瘤学研究培训计划
  • 批准号:
    10408197
  • 财政年份:
    2022
  • 资助金额:
    $ 49万
  • 项目类别:
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
早期病变转化和基础科学研究协调和数据管理中心
  • 批准号:
    10517004
  • 财政年份:
    2022
  • 资助金额:
    $ 49万
  • 项目类别:
Basic and Translational Studies in Redox Regulation of Cardiovascular Physiology and Disease
心血管生理和疾病氧化还原调节的基础和转化研究
  • 批准号:
    10544056
  • 财政年份:
    2022
  • 资助金额:
    $ 49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了